Imagine a world without disease.
A world where we join forces to accelerate the development of advanced medicines and ensure access to cures for all patients, everywhere.
Impact the lives of all patients needing a cure.
Make a donation.
Fuel innovative gene & cell therapy advancement and help us overcome the obstacles to delivering cures.
Join our community.
Learn how advanced medicines can cure, network with members, and collaborate on cutting-edge initiatives.
Here’s why:
0 million
people living with HIV worldwide, including 1.8 million children.
0 million
new cancer cases in 2018 with over 9.5 million deaths worldwide.
0
genetic disorders exist, many
of which are fatal or debilitating.
$0+
is the price for a one-time advanced therapy, not including hospital costs.
Such pricing is not sustainable in developed countries, let alone the developing world, leaving many without access to potential cures. We can do better.
Access to medicines that can cure is a basic human right, no matter who you are.
At Caring Cross, we believe that every person should be able to access advanced medicines at an affordable cost.
We enable access by building a community of caregivers, innovators, volunteers, and partners that collaborate to develop and deliver curative therapies for patients suffering from infectious diseases like HIV, cancer, genetic diseases, and other serious disorders.
Here’s how we do it:
Educational Events
We hold educational events to share the latest advanced medicinal innovations via talks, tutorials, and panel discussions.
Community Network
Our passionate community uses science & technology to develop and implement affordable curative medicines for all.
Cure Projects
We are developing curative medicines, that upon clinical success, will be made available to all who need them affordably and sustainably.
Impact Initiatives
We collaborate with organizations and create new initiatives to encourage affordable access of curative medicines for underserved communities worldwide.
Corporate Partnerships
We collaborate with companies and start new ones, developing curative medicines and technologies under agreements enabling affordable access.
